聚合搜Scholar - 壹搜网
Scholar
网盘
Scholar
视频
音乐
图片
网页
源码
软件
学术
书籍
⚙️ 搜索设置
时间筛选
时间不限
一天内
一周内
一月内
一年内
自定义
从
至
确定
所有网页和文件
PDF(.pdf)
Word(.doc)
Excel(.xls)
PowerPoint(.ppt)
RTF(.rtf)
确定
站点检索
确定
关闭
聚合搜Scholar - 壹搜网为您找到"
Flutter版本选择指南:3.41开始进入稳定区间 | 2026年3月
"相关结果 80条
基于多尺度的基本农田空间区位选择——以武汉城市圈为例
www.resci.cn
企业并购投资区位选择机理与效应的研究进展
www.progressingeography.com
区间对称矩阵渐近稳定的充要条件和充分条件
engine.scichina.com
螺杆泵定子材料耐磨性研究及选用指南
ojs.omniscient.sg
研修施設・研修関連施設 指定更新申請のご案内(2011年4月1日指定審査)
www.jstage.jst.go.jp
采暖建筑地基融区的最大融深和稳定时间的计算
engine.scichina.com
撞击坑统计定年法及对月球虹湾地区的定年结果
www.earth-science.net
大型灌区渠道衬砌形式的选择和应用
ojs.omniscient.sg
上一页
1
2
3
4
5
6
7
8
9
下一页
GitHub
热搜
1
Github
2
CYC GitHub
3
GitHub
4
GitHub dataset
5
Github file
6
GitHub
7
GitHub MUSAE
8
Vibe Coding with GitHub Copilot (Exploring GitHub Copilot Features)
9
Vibe Coding with GitHub Copilot (GitHub Copilot Chat in Developer Workflow)
10
Hands-on GitHub Actions (Introduction to GitHub Actions)
掘金
热搜
1
Ejin Formation
2
On Gudo-ejin's Endonkai-kikigaki
3
<b>Research on land desertification in Ejin Banner from 1991 to 2021</b><b> </b><b>based on Albedo-MSAVI feature space model</b>
4
The fortresses of Ejin: an example of outlining a site from satellite images
5
European Journal of Infusion Nursing
6
'Liquidity Risk and Its Determinants': A Study on Oil and Gas Industry in Tatneft
7
Geological Formation Names of China (1866–2000) (Ejin Formation)
8
Quantitative classification and analysis of relationships between plant communities and their groundwater environment in the Ejin Desert Oasis of China
9
Research on Land Desertification in Ejin Banner from 1991 to 2021 Based on Albedo-Msavi Feature Space Model
10
Ptpd Alloy Film-Coated Lipid Nanotubes for Glucose Fuel Cells in a Neutral Medium
科技期刊
热搜
1
AHA Journals - Tech Editors
2
Tech Rehearsal
3
Low tech, high tech, wild tech. Réinventer la technologie ?
4
Inter Tech
5
E-Tech 2004
6
Dry Tech Rehearsal
7
High Tech- Engineering Journal
8
Linnaeus Eco-Tech
9
Linnaeus Eco-Tech
10
Bio-tech, NanoBio-Tech, SynBio-tech, NanoSynBio-tech? The Changing Face of Biotech Law? (Part II)